Added to YB: 2024-09-09
Pitch date: 2024-09-09
HRMY [bullish]
Harmony Biosciences Holdings, Inc.
-9.67%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.
Market Cap
$2.2B
Pitch Price
$38.07
Price Target
N/A
Dividend
N/A
EV/EBITDA
6.56
P/E
11.80
EV/Sales
2.00
Sector
Pharmaceuticals
Category
growth
Show full summary:
Harmony Biosciences (HRMY)
HRMY: Single strong drug gaining market share rapidly due to non-scheduled/unrestricted status, an underappreciated advantage. Growth potential underestimated by market.